InNexus Biotechnology (InNexus Biotechnology) Accounts Payable & Accrued Expense : $2.93 Mil (As of Mar. 2011)

View and export this data going back to . Start your Free Trial

What is InNexus Biotechnology Accounts Payable & Accrued Expense?

InNexus Biotechnology's quarterly accounts payable & accrued expense increased from Sep. 2010 ($2.46 Mil) to Dec. 2010 ($2.67 Mil) and increased from Dec. 2010 ($2.67 Mil) to Mar. 2011 ($2.93 Mil).

InNexus Biotechnology's annual accounts payable & accrued expense increased from Jun. 2008 ($1.51 Mil) to Jun. 2009 ($3.58 Mil) and increased from Jun. 2009 ($3.58 Mil) to Jun. 2010 ($5.01 Mil).

InNexus Biotechnology Accounts Payable & Accrued Expense Historical Data

The historical data trend for InNexus Biotechnology's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

InNexus Biotechnology Accounts Payable & Accrued Expense Chart

InNexus Biotechnology Annual Data

Trend

Jun01

Jun02

Jun03

Jun04

Jun05

Jun06

Jun07

Jun08

Jun09

Jun10

Accounts Payable & Accrued Expense

Get a 7-Day Free Trial

0.07

0.52

1.51

3.58

5.01

InNexus Biotechnology Quarterly Data
	Jun06	Sep06	Dec06	Mar07	Jun07	Sep07	Dec07	Mar08	Jun08	Sep08	Dec08	Mar09	Jun09	Sep09	Dec09	Mar10	Jun10	Sep10	Dec10	Mar11
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial															2.71	5.01	2.46	2.67	2.93

InNexus Biotechnology Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

InNexus Biotechnology (InNexus Biotechnology) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » InNexus Biotechnology Inc (GREY:IXSBF) » Definitions » Accounts Payable & Accrued Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

1055 West Georgia Street, 1500 Royal Centre, Vancouver, BC, CAN, V6E 4N7

Website

http://www.ixsbio.com

InNexus Biotechnology Inc is engaged in commercializing the next generation of monoclonal antibodies based on its DXL technology, which improves the potency of existing antibody products while opening new markets and disease applications.

InNexus Biotechnology (InNexus Biotechnology) Headlines

No Headlines